Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004467725 | SCV004968595 | uncertain significance | Inborn genetic diseases | 2024-03-14 | criteria provided, single submitter | clinical testing | The c.2102T>C (p.L701P) alteration is located in exon 16 (coding exon 16) of the TMEM260 gene. This alteration results from a T to C substitution at nucleotide position 2102, causing the leucine (L) at amino acid position 701 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |